SCHEMBL16596176

SCHEMBL16596176

O=C(O)CCCCCCCOc1cccc(Br)c1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
KMT2A Q03164 2/20 0.62
MAPT P10636 1/20 0.62
KDM4E B2RXH2 8/20 0.58
LMNA P02545 2/20 0.57
MEN1 O00255 1/20 0.54
RAB9A P51151 1/20 0.54
MRGPRX4 Q96LA9 1/20 0.54
HDAC1 Q13547 1/20 0.53
HDAC2 Q92769 1/20 0.53
POLB P06746 1/20 0.52
GAA P10253 1/20 0.52
PPARA Q07869 1/20 0.51
FFAR1 O14842 1/20 0.51
PPARG P37231 1/20 0.51
PPARD Q03181 1/20 0.51
FABP1 P07148 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596171 1.00 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL16596197 1.00 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL16596174 0.98 ALDH1A1 (0.63) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL988490 0.94 ALDH1A1 (0.61) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL29676577 0.94 ALDH1A1 (0.61) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL29584120 0.89 KDM4E (0.61) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL3095787 0.89 KDM4E (0.61) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL30639265 0.89 PPARA (0.58) HDAC1HDAC2PPARAFFAR1FABP1
SCHEMBL2801030 0.85 MAOB (0.60) ALDH1A1KMT2AMAPTKDM4ELMNA
SCHEMBL4086003 0.83 CNR2 (0.67) HDAC1HDAC2PPARAFABP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
WO-2015042363-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES BLVRB, PGLS, GRHPR ALDH1A1 4735/4885KMT2A 4247/4885MAPT 4618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.